Prediction of Appropriate Defibrillator Therapy in Heart Failure Patients Treated With Cardiac Resynchronization Therapy

American Journal of Cardiology

Volumn 105, Issue 1, 2010, Pages 105-111

  Soliman, Osama I I ^a   Theuns, Dominic A M J ^a   van Dalen, Bas M ^a   Vletter, Wim B ^a   Nemes, Attila ^a   Jordaens, Luc J ^a   Balk, Aggie H H M ^a   ten Cate, Folkert J ^a   Geleijnse, Marcel L ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DIGOXIN;

ADULT; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; COMORBIDITY; CONTROLLED STUDY; DEFIBRILLATOR; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE OVERLOAD; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SUDDEN DEATH;

CARDIOTONIC AGENTS; DEATH, SUDDEN, CARDIAC; DECISION MAKING; DEFIBRILLATORS, IMPLANTABLE; DIGOXIN; ECHOCARDIOGRAPHY, DOPPLER; ELECTRIC COUNTERSHOCK; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; STROKE VOLUME; TIME FACTORS;

EID: 72149126442     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.08.659     Document Type: Article

References (30)

1. Swedberg K., Cleland J., Dargie H., Drexler H., Follath F., Komajda M., Tavazzi L., Smiseth O.A., Gavazzi A., Haverich A., Hoes A., Jaarsma T., Korewicki J., Levy S., Linde C., Lopez-Sendon J.L., Nieminen M.S., Pierard L., and Remme W.J. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): the Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 26 (2005) 1115-1140
2. Fish J.M., Brugada J., and Antzelevitch C. Potential proarrhythmic effects of biventricular pacing. J Am Coll Cardiol 46 (2005) 2340-2347
3. Higgins S.L., Hummel J.D., Niazi I.K., Giudici M.C., Worley S.J., Saxon L.A., Boehmer J.P., Higginbotham M.B., De Marco T., Foster E., and Yong P.G. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol 42 (2003) 1454-1459
4. Zagrodzky J.D., Ramaswamy K., Page R.L., Joglar J.A., Sheehan C.J., Smith M.L., and Hamdan M.H. Biventricular pacing decreases the inducibility of ventricular tachycardia in patients with ischemic cardiomyopathy. Am J Cardiol 87 (2001) 1208-1210
5. Cleland J.G., Daubert J.C., Erdmann E., Freemantle N., Gras D., Kappenberger L., and Tavazzi L. Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the Cardiac Resynchronization-Heart Failure (CARE-HF) trial extension phase]. Eur Heart J 27 (2006) 1928-1932
6. Saxon L.A., Bristow M.R., Boehmer J., Krueger S., Kass D.A., De Marco T., Carson P., DiCarlo L., Feldman A.M., Galle E., and Ecklund F. Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial. Circulation 114 (2006) 2766-2772
7. Soliman O.I., Theuns D.A., Geleijnse M.L., Anwar A.M., Nemes A., Caliskan K., Vletter W.B., Jordaens L.J., and Cate F.J. Spectral pulsed-wave tissue Doppler imaging lateral-to-septal delay fails to predict clinical or echocardiographic outcome after cardiac resynchronization therapy. Europace 9 (2007) 113-118
8. Theuns D.A., Thornton A.S., Klootwijk A.P., Scholten M.F., Vantrimpont P.J., Balk A.H., and Jordaens L.J. Outcome in patients with an ICD incorporating cardiac resynchronisation therapy: differences between primary and secondary prophylaxis. Eur J Heart Fail 7 (2005) 1027-1032
9. Lang R.M., Bierig M., Devereux R.B., Flachskampf F.A., Foster E., Pellikka P.A., Picard M.H., Roman M.J., Seward J., Shanewise J.S., Solomon S.D., Spencer K.T., Sutton M.S., and Stewart W.J. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18 (2005) 1440-1463
10. Soliman O.I., Theuns D.A., ten Cate F.J., Nemes A., Caliskan K., Balk A.H., Vletter W.B., Jordaens L.J., and Geleijnse M.L. Predictors of cardiac events after cardiac resynchronization therapy with tissue Doppler-derived parameters. J Card Fail 13 (2007) 805-811
11. Soliman O.I., Theuns D.A., ten Cate F.J., Anwar A.M., Nemes A., Vletter W.B., Jordaens L.J., and Geleijnse M.L. Baseline predictors of cardiac events after cardiac resynchronization therapy in patients with heart failure secondary to ischemic or nonischemic etiology. Am J Cardiol 100 (2007) 464-469
12. Zipes D.P., Camm A.J., Borggrefe M., Buxton A.E., Chaitman B., Fromer M., Gregoratos G., Klein G., Moss A.J., Myerburg R.J., Priori S.G., Quinones M.A., Roden D.M., Silka M.J., Tracy C., Smith Jr. S.C., Jacobs A.K., Adams C.D., Antman E.M., Anderson J.L., Hunt S.A., Halperin J.L., Nishimura R., Ornato J.P., Page R.L., Riegel B., Blanc J.J., Budaj A., Dean V., Deckers J.W., Despres C., Dickstein K., Lekakis J., McGregor K., Metra M., Morais J., Osterspey A., Tamargo J.L., and Zamorano J.L. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114 (2006) e385-e484
13. Bristow M.R., Saxon L.A., Boehmer J., Krueger S., Kass D.A., De Marco T., Carson P., DiCarlo L., DeMets D., White B.G., DeVries D.W., and Feldman A.M. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350 (2004) 2140-2150
14. Lam S.K., and Owen A. Combined resynchronisation and implantable defibrillator therapy in left ventricular dysfunction: Bayesian network meta-analysis of randomised controlled trials. BMJ 335 (2007) 925
15. Luu M., Stevenson W.G., Stevenson L.W., Baron K., and Walden J. Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. Circulation 80 (1989) 1675-1680
16. Soliman O.I., Geleijnse M.L., Theuns D.A., Nemes A., Vletter W.B., van Dalen B.M., Motawea A.K., Jordaens L.J., and Ten Cate F.J. Reverse of left ventricular volumetric and structural remodeling in heart failure patients treated with cardiac resynchronization therapy. Am J Cardiol 101 (2008) 651-657
17. Ypenburg C., van Erven L., Bleeker G.B., Bax J.J., Bootsma M., Wijffels M.C., van der Wall E.E., and Schalij M.J. Benefit of combined resynchronization and defibrillator therapy in heart failure patients with and without ventricular arrhythmias. J Am Coll Cardiol 48 (2006) 464-470
18. Whang W., Mittleman M.A., Rich D.Q., Wang P.J., Ruskin J.N., Tofler G.H., Muller J.E., and Albert C.M. Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers of Ventricular Arrhythmias (TOVA) study. Circulation 109 (2004) 1386-1391
19. Grimm W., Hoffmann J.J., Muller H.H., and Maisch B. Implantable defibrillator event rates in patients with idiopathic dilated cardiomyopathy, nonsustained ventricular tachycardia on Holter and a left ventricular ejection fraction below 30%. J Am Coll Cardiol 39 (2002) 780-787
20. De Maria R., Gavazzi A., Caroli A., Ometto R., Biagini A., Camerini F., and Italian Multicenter Cardiomyopathy Study (SPIC) Group. Ventricular arrhythmias in dilated cardiomyopathy as an independent prognostic hallmark. Am J Cardiol 69 (1992) 1451-1457
21. Doval H.C., Nul D.R., Grancelli H.O., Varini S.D., Soifer S., Corrado G., Dubner S., Scapin O., Perrone S.V., and GESICA-GEMA Investigators. Nonsustained ventricular tachycardia in severe heart failure. Independent marker of increased mortality due to sudden death. Circulation 94 (1996) 3198-3203
22. Tauke J., Goldstein S., and Gheorghiade M. Digoxin for chronic heart failure: a review of the randomized controlled trials with special attention to the PROVED (Prospective Randomized Study of Ventricular Failure and the Efficacy of Digoxin) and RADIANCE (Randomized Assessment of Digoxin on Inhibitors of the Angiotensin Converting Enzyme) trials. Prog Cardiovasc Dis 37 (1994) 49-58
23. Lown B., Graboys T.B., Podrid P.J., Cohen B.H., Stockman M.B., and Gaughan C.E. Effect of a digitalis drug on ventricular premature beats. N Engl J Med 296 (1977) 301-306
24. +)-ATPase and cardiac glycoside binding. J Clin Invest 57 (1976) 341-350
25. Ho A.T., Pai S.M., Timothy P., and Pai R.G. Effect of concomitant antiarrhythmic therapy on survival in patients with implantable cardioverter defibrillators. Pacing Clin Electrophysiol 28 (2005) 647-653
26. Packer M., Gheorghiade M., Young J.B., Costantini P.J., Adams K.F., Cody R.J., Smith L.K., Van Voorhees L., Gourley L.A., and Jolly M.K. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study. N Engl J Med 329 (1993) 1-7
27. Gasparini M., Auricchio A., Regoli F., Fantoni C., Kawabata M., Galimberti P., Pini D., Ceriotti C., Gronda E., Klersy C., Fratini S., and Klein H.H. Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation. J Am Coll Cardiol 48 (2006) 734-743
28. Bocker D., Bansch D., Heinecke A., Weber M., Brunn J., Hammel D., Borggrefe M., Breithardt G., and Block M. Potential benefit from implantable cardioverter-defibrillator therapy in patients with and without heart failure. Circulation 98 (1998) 1636-1643
29. Leor J., Goldbourt U., Rabinowitz B., Reicher-Reiss H., Boyko V., Kaplinsky E., Behar S., and SPRINT Study Group. Digoxin and increased mortality among patients recovering from acute myocardial infarction: importance of digoxin dose. Cardiovasc Drugs Ther 9 (1995) 723-729
30. Abraham W.T., Young J.B., Leon A.R., Adler S., Bank A.J., Hall S.A., Lieberman R., Liem L.B., O'Connell J.B., Schroeder J.S., and Wheelan K.R. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure. Circulation 110 (2004) 2864-2868